BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22448280)

  • 21. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate.
    Almeida SR; Aroeira LS; Frymuller E; Dias MA; Bogsan CS; Lopes JD; Mariano M
    Int Immunol; 2001 Sep; 13(9):1193-201. PubMed ID: 11526100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Babesia: the protective effects of killed Propionibacterium acnes on the infections of two rodent Babesia parasites in mice.
    Iseki H; Takabatake N; Ota N; Ishigame T; Yokoyama N; Igarashi I
    Exp Parasitol; 2008 Apr; 118(4):543-8. PubMed ID: 18164706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes.
    Kalis C; Gumenscheimer M; Freudenberg N; Tchaptchet S; Fejer G; Heit A; Akira S; Galanos C; Freudenberg MA
    J Immunol; 2005 Apr; 174(7):4295-300. PubMed ID: 15778393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages, rather than T and B cells are principal immunostimulatory target cells of Lycium barbarum L. polysaccharide LBPF4-OL.
    Zhang XR; Zhou WX; Zhang YX; Qi CH; Yan H; Wang ZF; Wang B
    J Ethnopharmacol; 2011 Jul; 136(3):465-72. PubMed ID: 21549827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propionibacterium acnes acts as an adjuvant in in vitro immunization of human peripheral blood mononuclear cells.
    Jung YS; Matsumoto SE; Yamashita M; Tomimatsu K; Teruya K; Katakura Y; Shirahata S
    Biosci Biotechnol Biochem; 2007 Aug; 71(8):1963-9. PubMed ID: 17690460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophages largely contribute to heterologous anti-Propionibacterium acnes antibody-mediated protection from Actinobacillus pleuropneumoniae infection in mice.
    Ma Q; Sun C; Yang F; Wang L; Qin W; Xia X; Feng X; Du C; Gu J; Han W; Lei L
    Microbiol Immunol; 2015 Mar; 59(3):166-73. PubMed ID: 25644652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced resistance to Gram-positive bacterium and increased susceptibility to bacterial endotoxin in mice sensitized with Propionibacterium acnes: involvement of Toll-like receptor.
    Mochizuki H; Nomura T; Kawamura I; Mitsuyama M
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):287-93. PubMed ID: 15681160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.
    Mussalem JS; Vasconcelos JR; Squaiella CC; Ananias RZ; Braga EG; Rodrigues MM; Longo-Maugéri IM
    Microbiol Immunol; 2006; 50(4):253-63. PubMed ID: 16625047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate, antigen-independent role for T cells in the activation of the immune system by Propionibacterium acnes.
    Tchaptchet S; Kirberg J; Freudenberg N; Schamel WW; Galanos C; Freudenberg MA
    Eur J Immunol; 2010 Sep; 40(9):2506-16. PubMed ID: 20690177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury.
    Margenthaler JA; Landeros K; Kataoka M; Eilers M; Ku G; Flye MW
    J Surg Res; 2003 Jun; 112(1):102-10. PubMed ID: 12873441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum.
    Soyka LF; Stephens CC; MacPherson BR; Foster RS
    Int J Immunopharmacol; 1979; 1(2):101-12. PubMed ID: 551956
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Independent regulation of MHC class II expression and induction of tumoricidal activity in bone marrow-derived mononuclear phagocytes.
    Keller R; Joller P; Keist R; Binz H; van der Meide PH
    Scand J Immunol; 1988 Jul; 28(1):113-21. PubMed ID: 2456605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo.
    Kistowska M; Gehrke S; Jankovic D; Kerl K; Fettelschoss A; Feldmeyer L; Fenini G; Kolios A; Navarini A; Ganceviciene R; Schauber J; Contassot E; French LE
    J Invest Dermatol; 2014 Mar; 134(3):677-685. PubMed ID: 24157462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9-dependent and independent pathways drive activation of the immune system by Propionibacterium acnes.
    Tchaptchet S; Gumenscheimer M; Kalis C; Freudenberg N; Hölscher C; Kirschning CJ; Lamers M; Galanos C; Freudenberg MA
    PLoS One; 2012; 7(6):e39155. PubMed ID: 22745710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LPS-induced migration of peritoneal B-1 cells is associated with upregulation of CXCR4 and increased migratory sensitivity to CXCL12.
    Moon H; Lee JG; Shin SH; Kim TJ
    J Korean Med Sci; 2012 Jan; 27(1):27-35. PubMed ID: 22219610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes.
    Yu Y; Champer J; Agak GW; Kao S; Modlin RL; Kim J
    J Invest Dermatol; 2016 Nov; 136(11):2221-2228. PubMed ID: 27377696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNIP1 Regulates
    Erdei L; Bolla BS; Bozó R; Tax G; Urbán E; Kemény L; Szabó K
    Front Immunol; 2018; 9():2155. PubMed ID: 30319618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic function in horses after non-specific immunostimulant administration.
    Flaminio MJ; Rush BR; Shuman W
    Vet Immunol Immunopathol; 1998 Jun; 63(4):303-15. PubMed ID: 9656421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.